Search

Your search keyword '"ADC Therapeutics S.A. -- Forecasts and trends"' showing total 5 results
Start Over Descriptor "ADC Therapeutics S.A. -- Forecasts and trends" Topic biopharmaceutics -- statistics
5 results on '"ADC Therapeutics S.A. -- Forecasts and trends"'

1. Antibody Drug Conjugates (ADC) Market worth $19.8 billion | MarketsandMarkets

Subjects
ADC Therapeutics S.A. -- Forecasts and trends, Biopharmaceutics -- Statistics, Independent regulatory commissions -- Forecasts and trends -- Statistics, Antineoplastic agents -- Statistics, Monoclonal antibodies -- Statistics -- Forecasts and trends, Pharmaceutical industry -- Statistics -- Forecasts and trends, Antimitotic agents -- Statistics, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

CHICAGO: MarketsandMarkets has issued the following news release: The Antibody Drug Conjugates (ADC) industry represents a cutting-edge and rapidly evolving sector within the field of biopharmaceuticals. ADCs are a class [...]

Published
2023

2. Antibody Drug Conjugates (ADC) Market worth $19.8 billion | MarketsandMarkets

Subjects
ADC Therapeutics S.A. -- Forecasts and trends, Biopharmaceutics -- Statistics, Independent regulatory commissions -- Forecasts and trends -- Statistics, Antineoplastic agents -- Statistics, Monoclonal antibodies -- Statistics -- Forecasts and trends, Pharmaceutical industry -- Statistics -- Forecasts and trends, Antimitotic agents -- Statistics, Market trend/market analysis, Business, News, opinion and commentary
Abstract

CHICAGO, Oct. 5, 2023 /PRNewswire/ -- The Antibody Drug Conjugates (ADC) industry represents a cutting-edge and rapidly evolving sector within the field of biopharmaceuticals. ADCs are a class of targeted [...]

Published
2023

3. Global Antibody Drug Conjugates (ADC) Markets, 2022-2028: Increasing Cases of Cancer with ADCs Showing to be a Substitute for Conventional Cancer Treatments Like Chemotherapy or Combination Therapy (Updated on September 15, 2022)

Subjects
United States. Food and Drug Administration -- Statistics, ADC Therapeutics S.A. -- Forecasts and trends, Seagen Inc. -- Forecasts and trends, Biopharmaceutics -- Statistics, Biotechnology industry -- Forecasts and trends -- Statistics, Viral antibodies -- Statistics -- Forecasts and trends, Chemotherapy -- Forecasts and trends -- Statistics, Cancer -- Chemotherapy, Antibodies -- Statistics -- Forecasts and trends, Pharmaceutical industry -- Statistics -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Global Antibody Drug Conjugates Market Size, Share & Industry Trends Analysis Report By Application, By Technology, By Regional Outlook [...]

Published
2022

4. Global Antibody Drug Conjugates (ADC) Market Analysis Report 2022: A $13.8 Billion Market by 2028 - Increased Investments by Key Industry Players

Subjects
United States. Food and Drug Administration -- Statistics -- Reports, ADC Therapeutics S.A. -- Forecasts and trends, Seagen Inc. -- Forecasts and trends, Biopharmaceutics -- Statistics, Biotechnology industry -- Forecasts and trends -- Statistics, Viral antibodies -- Statistics -- Reports -- Forecasts and trends, Antibodies -- Statistics -- Reports -- Forecasts and trends, Pharmaceutical industry -- Statistics -- Forecasts and trends, Investments -- Statistics, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

Dublin, Sep 08, 2022 (GLOBE NEWSWIRE via COMTEX) -- EQNX::TICKER_START EQNX::TICKER_END The 'Global Antibody Drug Conjugates Market Size, Share & Industry Trends Analysis Report By Application, By Technology, By Regional [...]

Published
2022

5. The Global Antibody Drug Conjugates Market size is expected to reach $13.8 billion by 2028, rising at a market growth of 14.2% CAGR during the forecast period

Subjects
United States. Food and Drug Administration -- Statistics -- Reports, Merck & Company Inc. -- Forecasts and trends, Astellas Pharma Inc. -- Forecasts and trends, Takeda Pharmaceutical Company Ltd. -- Forecasts and trends, ADC Therapeutics S.A. -- Forecasts and trends, GSK PLC -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Gilead Sciences Inc. -- Forecasts and trends, Seagen Inc. -- Forecasts and trends, Daiichi Sankyo Company Ltd. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Biological products industry -- Statistics -- Forecasts and trends, Biopharmaceutics -- Statistics, Biotechnology industry -- Forecasts and trends -- Statistics, Viral antibodies -- Statistics -- Reports -- Forecasts and trends, Chemotherapy -- Forecasts and trends -- Reports -- Statistics, Cancer -- Chemotherapy, Antibodies -- Statistics -- Reports -- Forecasts and trends, Pharmaceutical industry -- Statistics -- Forecasts and trends, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

New York, July 07, Jul 07, 2022 (GLOBE NEWSWIRE via COMTEX) -- EQNX::TICKER_START EQNX::TICKER_END Reportlinker.com announces the release of the report 'Global Antibody Drug Conjugates Market Size, Share & Industry [...]

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results